FindTrial
Sign In

Two local anaesthetic drugs are compared for spinal anaesthesia in patients undergoing ureteric stone removal.

Comparison of efficacy between equipotent doses of hyperbaric levobupivacaine with hyperbaric ropivacaine for ureteroscopic lithotripsy under spinal anaesthesia:A double blinded randomized control study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061720
Enrollment
60
Registered
2024-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N201- Calculus of ureter Health Condition 2: N39- Other disorders of urinary system Health Condition 3: N398- Other specified disorders of urinary system

Interventions

Intervention1: hyperbaric Levobupivacaine 0.5%: spinal anaesthesia in patients with ureteric stones undergoing URSL using hyperbaric Levobupivacaine 0.5% Control Intervention1: hyperbaric Ropivacaine

Sponsors

S Nijalingappa Medical College and HSK Hospital.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA physical status I-II 2.Body mass index 18-35kg/m2. 3.Patients undergoing Ureteroscopic lithotripsy (URSL) surgeries under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: 1.Patient refusal 2.Infection at needle insertion site. 3.Coagulopathy. 4.Allergic to local anaesthetics. 5.Psychiatric illness. 6.Spinal abnormalities.

Design outcomes

Primary

MeasureTime frame
To compare onset & duration of sensory & motor block of equipotent doses of intrathecal levobupivacaine with hyperbaric ropivacaine.Timepoint: 5hrs—

Secondary

MeasureTime frame
To Compare hemodynamic parameters & adverse effectsTimepoint: 45min—

Countries

India

Contacts

Public ContactDr Chaitra Konappanavar

S.Nijalingappa Medical College and HSK Hospital, Navanagar, Bagalkot.

anilganesh22@gmail.com996452698

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026